首页 > 最新文献

Journal of Global Infectious Diseases最新文献

英文 中文
Human Immunodeficiency Virus-positive Patients on Highly Active Antiretroviral Therapy Continue to Have a Decline in Renal Function Irrespective of Tenofovir Usage. 人类免疫缺陷病毒阳性患者在接受高活性抗逆转录病毒治疗时,不论是否使用替诺福韦,肾功能都持续下降。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-09-27 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_125_23
Kavita Sanjeev Joshi, Viplove Fulsing Jadhao, Rushabh Gujarathi, Widhi Churiwala, Anuya Ajit Natu

Introduction: Human immunodeficiency virus (HIV) patients may undergo renal damage due to disease or nephrotoxic drugs. Tenofovir has been associated with the development of renal impairment. The aim of this study was to compare trends in creatinine clearance (CrCl) and estimated glomerular filtration rate (eGFR) in patients on highly active antiretroviral therapy (HAART) and to compare the same between patients on tenofovir- and nontenofovir-based regimens.

Methods: A prospective observational study was conducted. We followed 244 patients for 2 years. The demographic, clinical, and laboratory parameters of the patients were recorded at baseline, 1 year of therapy, and 2 years of therapy. The data were analyzed using dividing patients into tenofovir- and nontenofovir-based groups. Statistical analysis was performed using the Chi-square test, paired and unpaired t-tests, and Fisher's exact test.

Results: The mean blood urea nitrogen and serum creatinine in both groups were comparable at the start of the therapy. The decline in CrCl and eGFR in all patients on HAART for 2 years was statistically significant, irrespective of tenofovir usage. The mean decrease in eGFR in the tenofovir group was 12.4 mL/min/1.73 m2 and in the nontenofovir group, 9 mL/min/1.73 m2, though the differences between eGFR and CrCl were not significant between the two groups at any point.

Conclusion: Even though previous studies have suggested that HAART usage can slow the decline in kidney function in people living with HIV, patients who receive HAART still show a statistically significant decline in renal function parameters, akin to the observations of other such studies in low-resource settings.

人类免疫缺陷病毒(HIV)患者可能由于疾病或肾毒性药物而导致肾脏损害。替诺福韦与肾脏损害的发生有关。本研究的目的是比较高活性抗逆转录病毒治疗(HAART)患者的肌酐清除率(CrCl)和估计肾小球滤过率(eGFR)的趋势,并比较以替诺福韦和非替诺福韦为基础的方案的患者之间的相同趋势。方法:采用前瞻性观察研究。我们对244例患者进行了2年的随访。在基线、治疗1年和治疗2年时记录患者的人口学、临床和实验室参数。将患者分为替诺福韦组和非替诺福韦组对数据进行分析。统计分析采用卡方检验、配对和非配对t检验和Fisher精确检验。结果:两组患者在治疗开始时的平均尿素氮和血清肌酐具有可比性。不论是否使用替诺福韦,所有接受HAART治疗2年的患者中CrCl和eGFR的下降都具有统计学意义。替诺福韦组的eGFR平均下降为12.4 mL/min/1.73 m2,非替诺福韦组的eGFR平均下降为9 mL/min/1.73 m2,但两组之间的eGFR和CrCl在任何时候都没有显著差异。结论:尽管先前的研究表明,使用HAART可以减缓HIV感染者肾功能的下降,但接受HAART治疗的患者在肾功能参数上仍显示出统计学上显著的下降,这与其他在低资源环境下进行的此类研究的观察结果相似。
{"title":"Human Immunodeficiency Virus-positive Patients on Highly Active Antiretroviral Therapy Continue to Have a Decline in Renal Function Irrespective of Tenofovir Usage.","authors":"Kavita Sanjeev Joshi, Viplove Fulsing Jadhao, Rushabh Gujarathi, Widhi Churiwala, Anuya Ajit Natu","doi":"10.4103/jgid.jgid_125_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_125_23","url":null,"abstract":"<p><strong>Introduction: </strong>Human immunodeficiency virus (HIV) patients may undergo renal damage due to disease or nephrotoxic drugs. Tenofovir has been associated with the development of renal impairment. The aim of this study was to compare trends in creatinine clearance (CrCl) and estimated glomerular filtration rate (eGFR) in patients on highly active antiretroviral therapy (HAART) and to compare the same between patients on tenofovir- and nontenofovir-based regimens.</p><p><strong>Methods: </strong>A prospective observational study was conducted. We followed 244 patients for 2 years. The demographic, clinical, and laboratory parameters of the patients were recorded at baseline, 1 year of therapy, and 2 years of therapy. The data were analyzed using dividing patients into tenofovir- and nontenofovir-based groups. Statistical analysis was performed using the Chi-square test, paired and unpaired <i>t</i>-tests, and Fisher's exact test.</p><p><strong>Results: </strong>The mean blood urea nitrogen and serum creatinine in both groups were comparable at the start of the therapy. The decline in CrCl and eGFR in all patients on HAART for 2 years was statistically significant, irrespective of tenofovir usage. The mean decrease in eGFR in the tenofovir group was 12.4 mL/min/1.73 m<sup>2</sup> and in the nontenofovir group, 9 mL/min/1.73 m<sup>2</sup>, though the differences between eGFR and CrCl were not significant between the two groups at any point.</p><p><strong>Conclusion: </strong>Even though previous studies have suggested that HAART usage can slow the decline in kidney function in people living with HIV, patients who receive HAART still show a statistically significant decline in renal function parameters, akin to the observations of other such studies in low-resource settings.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"111-116"},"PeriodicalIF":1.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Scrub Typhus Encephalitis Assessment Tool for the Management of Acute Encephalitis Syndrome. 急性脑炎综合征管理中恙虫病脑炎评估工具的验证。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_194_23
Rama Shankar Rath, Rizwan S Abdulkader, Neha Srivastava, Hirawati Deval, Urmila Gupta, Bhoopendra Sharma, Mahim Mittal, Vijay Singh, Manish Kumar, Pradip Kharya, Nivedita Gupta, Rajni Kant, Manoj Murhekar, Mahima Mittal

Introduction: Acute encephalitis syndrome (AES) is one of the important causes of mortality among children in India. Active management of the cases, followed by addressing the cause of AES, is the key strategy for preventing mortality. Lack of laboratory facility and difficulty of sampling blood and cerebrospinal fluid (CSF) for assessing causes is one of the important barriers to early initiation of treatment. The main objective of the study is to validate the Scrub Typhus Encephalitis Assessment Tool (SEAT) for the management of AES.

Methods: The study is a continuation of a study conducted in a tertiary care hospital in Eastern Uttar Pradesh. A machine learning (LightGBM) model was built to predict the probability of scrub typhus diagnosis among patients with acute encephalitis. Three models were built: one with sociodemographic characters, the second with Model 1 variables and blood parameters, and the third with Model 2 variables and CSF parameters.

Results: The sensitivity of diagnosing the scrub typhus case was 71%, 77.5%, and 83% in Model 1, Model 2, and Model 3, respectively, and specificity was 61.5%, 75.5%, and 76.3%, respectively, in the models. In Model 1 fever duration, in Models 2 and 3, neutrophil/lymphocyte ratio was the most important predictor for differentiating the scrub and nonscrub cases.

Conclusion: With the available sensitivity and specificity of the tool, the SEAT can be a valuable tool for the prediction of scrub typhus as a cause of AES cases in remote areas.

简介:急性脑炎综合征(AES)是印度儿童死亡的重要原因之一。积极管理病例,然后解决不良反应的原因,是预防死亡的关键策略。缺乏实验室设施和采集血液和脑脊液(CSF)以评估病因的困难是早期开始治疗的重要障碍之一。本研究的主要目的是验证恙虫病脑炎评估工具(SEAT)对AES管理的有效性。方法:该研究是在北方邦东部一家三级护理医院进行的一项研究的延续。建立机器学习(LightGBM)模型预测急性脑炎患者恙虫病的诊断概率。建立了三个模型:一个是社会人口学特征模型,第二个是模型1变量和血液参数模型,第三个是模型2变量和CSF参数模型。结果:模型1、模型2、模型3诊断恙虫病病例的敏感性分别为71%、77.5%、83%,特异性分别为61.5%、75.5%、76.3%。在模型1、模型2和模型3中,中性粒细胞/淋巴细胞比率是区分擦洗和非擦洗病例的最重要预测因子。结论:该方法具有良好的敏感性和特异性,可作为预测偏远地区恙虫病病因的有效工具。
{"title":"Validation of the Scrub Typhus Encephalitis Assessment Tool for the Management of Acute Encephalitis Syndrome.","authors":"Rama Shankar Rath, Rizwan S Abdulkader, Neha Srivastava, Hirawati Deval, Urmila Gupta, Bhoopendra Sharma, Mahim Mittal, Vijay Singh, Manish Kumar, Pradip Kharya, Nivedita Gupta, Rajni Kant, Manoj Murhekar, Mahima Mittal","doi":"10.4103/jgid.jgid_194_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_194_23","url":null,"abstract":"<p><strong>Introduction: </strong>Acute encephalitis syndrome (AES) is one of the important causes of mortality among children in India. Active management of the cases, followed by addressing the cause of AES, is the key strategy for preventing mortality. Lack of laboratory facility and difficulty of sampling blood and cerebrospinal fluid (CSF) for assessing causes is one of the important barriers to early initiation of treatment. The main objective of the study is to validate the Scrub Typhus Encephalitis Assessment Tool (SEAT) for the management of AES.</p><p><strong>Methods: </strong>The study is a continuation of a study conducted in a tertiary care hospital in Eastern Uttar Pradesh. A machine learning (LightGBM) model was built to predict the probability of scrub typhus diagnosis among patients with acute encephalitis. Three models were built: one with sociodemographic characters, the second with Model 1 variables and blood parameters, and the third with Model 2 variables and CSF parameters.</p><p><strong>Results: </strong>The sensitivity of diagnosing the scrub typhus case was 71%, 77.5%, and 83% in Model 1, Model 2, and Model 3, respectively, and specificity was 61.5%, 75.5%, and 76.3%, respectively, in the models. In Model 1 fever duration, in Models 2 and 3, neutrophil/lymphocyte ratio was the most important predictor for differentiating the scrub and nonscrub cases.</p><p><strong>Conclusion: </strong>With the available sensitivity and specificity of the tool, the SEAT can be a valuable tool for the prediction of scrub typhus as a cause of AES cases in remote areas.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"92-97"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Peculiar Case of Disseminated Melioidosis with Atypical Features Likely Linked to Bong/Water Pipe Use.
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-10-01 DOI: 10.4103/jgid.jgid_5_24
Kisen Jang, Anmol Sharma

Melioidosis, caused by Burkholderia pseudomallei, is a challenging infectious disease with global implications, primarily affecting Southeast Asia. We present the case of a 24-year-old male with a curious history of tobacco use, presenting with fevers, weight loss, and genitourinary symptoms. Diagnostic challenges arose as symptoms mimicked other diseases. Disseminated melioidosis was confirmed via Gram staining and positron emission tomography scan findings, emphasizing the disease's diverse clinical manifestations. Treatment with ceftazidime and cotrimoxazole led to prompt recovery. Notably, the patient's tobacco use linked to contaminated water highlights a unique transmission route. This case underscores the need for heightened awareness and preventive measures in endemic regions.

{"title":"A Peculiar Case of Disseminated Melioidosis with Atypical Features Likely Linked to Bong/Water Pipe Use.","authors":"Kisen Jang, Anmol Sharma","doi":"10.4103/jgid.jgid_5_24","DOIUrl":"10.4103/jgid.jgid_5_24","url":null,"abstract":"<p><p>Melioidosis, caused by <i>Burkholderia pseudomallei</i>, is a challenging infectious disease with global implications, primarily affecting Southeast Asia. We present the case of a 24-year-old male with a curious history of tobacco use, presenting with fevers, weight loss, and genitourinary symptoms. Diagnostic challenges arose as symptoms mimicked other diseases. Disseminated melioidosis was confirmed via Gram staining and positron emission tomography scan findings, emphasizing the disease's diverse clinical manifestations. Treatment with ceftazidime and cotrimoxazole led to prompt recovery. Notably, the patient's tobacco use linked to contaminated water highlights a unique transmission route. This case underscores the need for heightened awareness and preventive measures in endemic regions.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 4","pages":"183-185"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11775393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Cardiovascular Risk Profile and Risk Scores of Antiretroviral Therapy-naïve HIV Patients in Eastern India. 印度东部抗逆转录病毒Therapy-naïve HIV患者心血管风险概况和风险评分的评估。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_29_24
Manaswi Chaubey, Jaya Chakravarty, Rishabh Gupta, Parth Jethwani, Rahul Puri, Shyam Sundar

Introduction: People living with human immunodeficiency virus (PLHIV) are known to have an increased prevalence of traditional cardiovascular risk factors and are at a higher risk of cardiovascular disease (CVD). This study was done to assess the CVD risk factors in treatment naïve PLHIV in a center of the national program.

Methods: In this cross-sectional explorative study, traditional CVD risk factors were assessed, and 10-year Framingham and atherosclerotic cardiovascular disease (ASCVD) risk score were calculated in treatment naïve PLHIV attending the antiretroviral therapy (ART) center, IMS, BHU.

Results: The study included 337 ART naïve patients. The prevalence of CVD risk factors in treatment naïve PLHIV - were low high-density lipoprotein cholesterol levels (81.4%), high triglyceride levels (32.7%), smoking (32.3%), obesity (13.6%), hypertension (5%), diabetes (2.7%), and high low-density lipoprotein cholesterol levels (2.1%). Moderate-to-high 10-year Framingham Risk Score and American Heart Association/American College of Cardiology 10-year ASCVD risk score were 10.8% and 8.9%, respectively. In Framingham Risk Score, age ≥40 years (odds ratio [OR] - 131) (95% confidence interval [CI] - 6.5-1043) alcohol intake (OR - 5.14 [95% CI - 1.82-14.46] and presence of tuberculosis (OR - 4.78) (95% CI - 1.48-15.40), while in ASCVD risk score history of alcohol intake (OR - 26.20 [95% CI - 3.1-216.8] were at higher risk of CVD in multivariate variate analysis.

Conclusion: CVD risk factors were common among ART naïve patient. Thus, screening, education, and treatment of CVD risk factors should be done in these patients at initiation of care.

人类免疫缺陷病毒(PLHIV)感染者已知传统心血管危险因素的患病率增加,并且心血管疾病(CVD)的风险更高。本研究是在国家项目中心评估治疗naïve PLHIV的心血管疾病危险因素。方法:在这项横断面探索性研究中,评估传统的CVD危险因素,并计算在抗逆转录病毒治疗(ART)中心、IMS、BHU治疗naïve PLHIV的10年Framingham和动脉粥样硬化性心血管疾病(ASCVD)风险评分。结果:研究纳入337例ART naïve患者。治疗中心血管疾病的危险因素naïve PLHIV -患病率为低高密度脂蛋白胆固醇水平(81.4%)、高甘油三酯水平(32.7%)、吸烟(32.3%)、肥胖(13.6%)、高血压(5%)、糖尿病(2.7%)和高低密度脂蛋白胆固醇水平(2.1%)。中高10年Framingham风险评分和美国心脏协会/美国心脏病学会10年ASCVD风险评分分别为10.8%和8.9%。在Framingham风险评分中,年龄≥40岁(比值比[OR] - 131)(95%可信区间[CI] - 6.5-1043)、酒精摄入(OR - 5.14 [95% CI - 1.82-14.46]和存在结核病(OR - 4.78) (95% CI - 1.48-15.40),而在ASCVD风险评分中,酒精摄入史(OR - 26.20 [95% CI - 3.1-216.8])发生CVD的风险较高。结论:心血管疾病危险因素在ART naïve患者中普遍存在。因此,筛查、教育和治疗心血管疾病的危险因素应在这些患者开始治疗。
{"title":"Evaluation of Cardiovascular Risk Profile and Risk Scores of Antiretroviral Therapy-naïve HIV Patients in Eastern India.","authors":"Manaswi Chaubey, Jaya Chakravarty, Rishabh Gupta, Parth Jethwani, Rahul Puri, Shyam Sundar","doi":"10.4103/jgid.jgid_29_24","DOIUrl":"https://doi.org/10.4103/jgid.jgid_29_24","url":null,"abstract":"<p><strong>Introduction: </strong>People living with human immunodeficiency virus (PLHIV) are known to have an increased prevalence of traditional cardiovascular risk factors and are at a higher risk of cardiovascular disease (CVD). This study was done to assess the CVD risk factors in treatment naïve PLHIV in a center of the national program.</p><p><strong>Methods: </strong>In this cross-sectional explorative study, traditional CVD risk factors were assessed, and 10-year Framingham and atherosclerotic cardiovascular disease (ASCVD) risk score were calculated in treatment naïve PLHIV attending the antiretroviral therapy (ART) center, IMS, BHU.</p><p><strong>Results: </strong>The study included 337 ART naïve patients. The prevalence of CVD risk factors in treatment naïve PLHIV - were low high-density lipoprotein cholesterol levels (81.4%), high triglyceride levels (32.7%), smoking (32.3%), obesity (13.6%), hypertension (5%), diabetes (2.7%), and high low-density lipoprotein cholesterol levels (2.1%). Moderate-to-high 10-year Framingham Risk Score and American Heart Association/American College of Cardiology 10-year ASCVD risk score were 10.8% and 8.9%, respectively. In Framingham Risk Score, age ≥40 years (odds ratio [OR] - 131) (95% confidence interval [CI] - 6.5-1043) alcohol intake (OR - 5.14 [95% CI - 1.82-14.46] and presence of tuberculosis (OR - 4.78) (95% CI - 1.48-15.40), while in ASCVD risk score history of alcohol intake (OR - 26.20 [95% CI - 3.1-216.8] were at higher risk of CVD in multivariate variate analysis.</p><p><strong>Conclusion: </strong>CVD risk factors were common among ART naïve patient. Thus, screening, education, and treatment of CVD risk factors should be done in these patients at initiation of care.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"104-110"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features of Candida Catheter-related Bloodstream Infections and Persistent Infections Associated with Early Catheter Reinsertion: A 6-year Retrospective Study. 念珠菌导管相关血流感染和持续性感染与早期导管重新插入相关的临床特征:一项6年回顾性研究。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_17_24
Takehito Kobayashi, Itaru Nakamura, Masaki Machida, Hidehiro Watanabe

Introduction: Catheter-related persistent Candida infections (CRPCI) may develop after Candida catheter-related bloodstream infections (CRBSI) due to colonization of the newly inserted catheter. However, the optimal timing for new catheter insertion remains controversial. The aim of this study was to determine the clinical features of CRBSI due to Candida species and CRPCI. This was a retrospective study conducted in a teaching hospital in Japan.

Methods: We retrospectively collected clinical information on hospitalized patients diagnosed with Candida CRBSIs by catheter tip culture from 2015 to 2020. CRPCI was defined as the growth of the same Candida species from the tip culture of a newly inserted catheter after the onset of a Candida CRBSI. The Chi-squared and Fisher's exact tests were used to compare differences between the case and control groups.

Results: Sixty-three cases of Candida CRBSI were collected. Fifty-four (85.7%) received total parenteral nutrition. CRPCI developed in 12 (48%) patients of the 25 in whom cultures of newly inserted catheters were performed. Despite antifungal therapy in these patients, persistent fungemia incidence was significantly higher (50.0% vs. 9.1%, odds ratio = 10.0, P = 0.033). The mean number of days from removal of infected catheter to reinsertion was significantly shorter for patients with CRPCI (0.27 days vs. 3.08 days, P = 0.038).

Conclusions: Total parenteral nutrition may be a major risk factor in the development of Candida CRBSI. CRPCI often leads to persistent fungemia. Early insertion of a new catheter after removal of an infected catheter may be a risk factor for CRPCI.

导读:导管相关持续性念珠菌感染(CRPCI)可能发生在念珠菌导管相关血流感染(CRBSI)后,由于新插入导管的定植。然而,新导管的最佳插入时间仍然存在争议。本研究的目的是确定由念珠菌种类和CRPCI引起的CRBSI的临床特征。这是一项在日本一家教学医院进行的回顾性研究。方法:回顾性收集2015 ~ 2020年通过导管尖端培养诊断为念珠菌CRBSIs的住院患者的临床资料。CRPCI定义为念珠菌CRBSI发生后,新插入导管的尖端培养产生相同念珠菌的生长。卡方检验和Fisher精确检验用于比较病例组和对照组之间的差异。结果:共收集到63例CRBSI念珠菌。54例(85.7%)接受全肠外营养。在25例进行新插入导管培养的患者中,有12例(48%)出现CRPCI。尽管对这些患者进行了抗真菌治疗,但持续性真菌血症的发生率明显较高(50.0% vs. 9.1%,优势比= 10.0,P = 0.033)。CRPCI患者从拔出感染导管到重新插入的平均天数显著缩短(0.27天比3.08天,P = 0.038)。结论:全肠外营养可能是念珠菌CRBSI发生的主要危险因素。CRPCI常导致持续性真菌血症。在取出感染导管后早期插入新导管可能是CRPCI的一个危险因素。
{"title":"Clinical Features of <i>Candida</i> Catheter-related Bloodstream Infections and Persistent Infections Associated with Early Catheter Reinsertion: A 6-year Retrospective Study.","authors":"Takehito Kobayashi, Itaru Nakamura, Masaki Machida, Hidehiro Watanabe","doi":"10.4103/jgid.jgid_17_24","DOIUrl":"https://doi.org/10.4103/jgid.jgid_17_24","url":null,"abstract":"<p><strong>Introduction: </strong>Catheter-related persistent <i>Candida</i> infections (CRPCI) may develop after <i>Candida</i> catheter-related bloodstream infections (CRBSI) due to colonization of the newly inserted catheter. However, the optimal timing for new catheter insertion remains controversial. The aim of this study was to determine the clinical features of CRBSI due to <i>Candida</i> species and CRPCI. This was a retrospective study conducted in a teaching hospital in Japan.</p><p><strong>Methods: </strong>We retrospectively collected clinical information on hospitalized patients diagnosed with <i>Candida</i> CRBSIs by catheter tip culture from 2015 to 2020. CRPCI was defined as the growth of the same <i>Candida</i> species from the tip culture of a newly inserted catheter after the onset of a <i>Candida</i> CRBSI. The Chi-squared and Fisher's exact tests were used to compare differences between the case and control groups.</p><p><strong>Results: </strong>Sixty-three cases of <i>Candida</i> CRBSI were collected. Fifty-four (85.7%) received total parenteral nutrition. CRPCI developed in 12 (48%) patients of the 25 in whom cultures of newly inserted catheters were performed. Despite antifungal therapy in these patients, persistent fungemia incidence was significantly higher (50.0% vs. 9.1%, odds ratio = 10.0, <i>P</i> = 0.033). The mean number of days from removal of infected catheter to reinsertion was significantly shorter for patients with CRPCI (0.27 days vs. 3.08 days, <i>P</i> = 0.038).</p><p><strong>Conclusions: </strong>Total parenteral nutrition may be a major risk factor in the development of <i>Candida</i> CRBSI. CRPCI often leads to persistent fungemia. Early insertion of a new catheter after removal of an infected catheter may be a risk factor for CRPCI.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"85-91"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fungal Pneumonia in a Diabetic Female Masquerading as Primary Lung Cancer. 伪装成原发性肺癌的糖尿病女性真菌性肺炎。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_160_23
Vishal Mangal, Sudipt Adhikari, Yadvir Garg, Anil Vasudev

Aspergillus is a ubiquitous saprophytic mold that humans and animals constantly inhale. In health, the conidia are eliminated by the innate immune system. However, a subset of individuals with risk factors such as neutropenia, receiving high doses of glucocorticoids or certain biologicals, and recipients of hematopoietic or solid-organ transplants develop invasive aspergillosis. The mortality associated with invasive aspergillosis is 42%-64%. The early diagnosis of invasive pulmonary aspergillosis in patients without classical risk factors remains challenging. We present a case of an elderly female with uncontrolled diabetes mellitus who presented with acute-onset chest pain, breathlessness, and cough without expectoration. On evaluation, her chest radiograph showed a mass lesion in the right upper zone. 18Fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography showed two FDG-avid lesions in the apical and medial segment of the right upper lobe. The lung biopsy was negative for malignancy; however, she was diagnosed with invasive pulmonary aspergillosis based on serum and bronchoalveolar fluid galactomannan positivity. She was managed with voriconazole with complete resolution of the lesion.

曲霉是一种无处不在的腐生霉菌,人类和动物经常吸入。在健康情况下,分生孢子会被先天免疫系统清除。然而,有嗜中性粒细胞减少症、接受高剂量糖皮质激素或某些生物制剂、以及接受造血或实体器官移植的个体会发生侵袭性曲霉病。侵袭性曲霉病的死亡率为42%-64%。无典型危险因素的侵袭性肺曲霉病的早期诊断仍然具有挑战性。我们报告一例老年女性糖尿病患者,其表现为急性发作胸痛、呼吸困难和无咳痰的咳嗽。经检查,她的胸片显示右上区有肿块。18氟脱氧葡萄糖(FDG)-正电子发射断层扫描-计算机断层扫描显示右上叶顶端和内侧段两个FDG-avid病变。肺活检呈恶性阴性;然而,根据血清和支气管肺泡液半乳甘露聚糖阳性,她被诊断为侵袭性肺曲霉病。经伏立康唑治疗,病变完全消退。
{"title":"Fungal Pneumonia in a Diabetic Female Masquerading as Primary Lung Cancer.","authors":"Vishal Mangal, Sudipt Adhikari, Yadvir Garg, Anil Vasudev","doi":"10.4103/jgid.jgid_160_23","DOIUrl":"https://doi.org/10.4103/jgid.jgid_160_23","url":null,"abstract":"<p><p><i>Aspergillus</i> is a ubiquitous saprophytic mold that humans and animals constantly inhale. In health, the conidia are eliminated by the innate immune system. However, a subset of individuals with risk factors such as neutropenia, receiving high doses of glucocorticoids or certain biologicals, and recipients of hematopoietic or solid-organ transplants develop invasive aspergillosis. The mortality associated with invasive aspergillosis is 42%-64%. The early diagnosis of invasive pulmonary aspergillosis in patients without classical risk factors remains challenging. We present a case of an elderly female with uncontrolled diabetes mellitus who presented with acute-onset chest pain, breathlessness, and cough without expectoration. On evaluation, her chest radiograph showed a mass lesion in the right upper zone. <sup>18</sup>Fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography showed two FDG-avid lesions in the apical and medial segment of the right upper lobe. The lung biopsy was negative for malignancy; however, she was diagnosed with invasive pulmonary aspergillosis based on serum and bronchoalveolar fluid galactomannan positivity. She was managed with voriconazole with complete resolution of the lesion.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"117-119"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cienciometric Analysis of Scientific Production on Hydatidosis/Echinococcosis in Latin America. 拉丁美洲包虫病/棘球蚴病科学成果的计量学分析。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-08-07 eCollection Date: 2024-07-01 DOI: 10.4103/jgid.jgid_28_24
Luz Angela Roman, Gustavo Tapia-Sequeiros, Maryorie Katteryne Galeas-Torre, Victor Roman-Lazarte

Introduction: Hydatidosis/cystic echinococcosis (CE) is considered a neglected disease due to its preventive nature and impact on low-income populations. In Latin America, there is a high incidence, and in the high Andean regions, it is considered an endemic disease. The objective of this study was to quantify and analyze the scientific production of hydatidosis/echinococcosis through a bibliometric analysis in Latin America up to 2022.

Methods: A bibliometric analysis study was conducted based on the scientific production of CE in the SCOPUS database until 2022 in Latin American countries. Information was collected through a systematic search. Frequencies and percentages were used to summarize the variables captured in the final database.

Results: Scientific production showed growth over the years, with Argentina, Uruguay, and Chile having the highest production. In addition, there has been a trending use of the term "neglected disease" since 2018. The most cited articles were primarily narrative reviews, book chapters, and original articles in that order. Only 27% of the studies were funded by an institution in Latin America.

Conclusion: Scientific production in Latin America regarding CE is on the rise, especially in countries with high incidence rates. Furthermore, these countries demonstrate a significant network of international collaboration.

简介:包虫病/囊性包虫病(CE)被认为是一种被忽视的疾病,因为它的预防性和低收入人群的影响。在拉丁美洲,发病率很高,在安第斯高原地区,它被认为是一种地方病。本研究的目的是通过文献计量学分析,量化和分析截至2022年拉丁美洲包虫病/棘球蚴病的科学产量。方法:基于SCOPUS数据库中截止2022年拉美国家CE的科学产出进行文献计量学分析研究。信息是通过系统搜索收集的。频率和百分比用于总结最终数据库中捕获的变量。结果:科研产量逐年增长,其中阿根廷、乌拉圭和智利产量最高。此外,自2018年以来,“被忽视的疾病”一词的使用呈趋势。被引用最多的文章依次是叙述性评论、书籍章节和原创文章。只有27%的研究是由拉丁美洲的机构资助的。结论:拉丁美洲关于CE的科学成果正在增加,特别是在高发病率的国家。此外,这些国家展示了一个重要的国际合作网络。
{"title":"Cienciometric Analysis of Scientific Production on Hydatidosis/Echinococcosis in Latin America.","authors":"Luz Angela Roman, Gustavo Tapia-Sequeiros, Maryorie Katteryne Galeas-Torre, Victor Roman-Lazarte","doi":"10.4103/jgid.jgid_28_24","DOIUrl":"https://doi.org/10.4103/jgid.jgid_28_24","url":null,"abstract":"<p><strong>Introduction: </strong>Hydatidosis/cystic echinococcosis (CE) is considered a neglected disease due to its preventive nature and impact on low-income populations. In Latin America, there is a high incidence, and in the high Andean regions, it is considered an endemic disease. The objective of this study was to quantify and analyze the scientific production of hydatidosis/echinococcosis through a bibliometric analysis in Latin America up to 2022.</p><p><strong>Methods: </strong>A bibliometric analysis study was conducted based on the scientific production of CE in the SCOPUS database until 2022 in Latin American countries. Information was collected through a systematic search. Frequencies and percentages were used to summarize the variables captured in the final database.</p><p><strong>Results: </strong>Scientific production showed growth over the years, with Argentina, Uruguay, and Chile having the highest production. In addition, there has been a trending use of the term \"neglected disease\" since 2018. The most cited articles were primarily narrative reviews, book chapters, and original articles in that order. Only 27% of the studies were funded by an institution in Latin America.</p><p><strong>Conclusion: </strong>Scientific production in Latin America regarding CE is on the rise, especially in countries with high incidence rates. Furthermore, these countries demonstrate a significant network of international collaboration.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 3","pages":"98-103"},"PeriodicalIF":1.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associated Risk Factors and Clinical Outcomes of Bloodstream Infections among COVID-19 Intensive Care Unit Patients in a Tertiary Care Hospital. 一家三级医院 COVID-19 重症监护病房患者血流感染的相关风险因素和临床结果。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_108_23
Mahalakshmamma Dasarahalli Shivalingappa, Supriya Gachinmath, Shiva Kumar Narayan

Introduction: The COVID-19 infection is an ongoing public health crisis causing millions of deaths worldwide. COVID-19 patients admitted to the intensive care unit (ICU) are more vulnerable to acquire secondary bloodstream infections (sBSIs) which cause a significant morbidity and mortality. Thus, we aim to assess the risk factors of sBSIs and outcomes in COVID-19 ICU patients.

Methods: One hundred blood culture samples with growth (cases) and other 100 blood culture with no growth(controls) were collected.. All the demographic data, laboratory data and antimicrobial resistance pattern were analysed . Blood culture bottle received in the Microbiology laboratory were loaded into Automated blood culture system. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing.

Results: Raised C-reactive protein (CRP) (P = 0.0035), interleukin-6 (P = 0.0404), mechanical ventilation (MV) (P = 0.024), prior antimicrobial exposure (P = 0.002), longer ICU stay with median 11 days (P = 0.022), and higher mortality rate (P = 0.001) were significantly associated with the BSI. A significant proportion of BSIs were Gram-negative bacteria (n = 115) such as Acinetobacter baumannii 38 (33%) and Klebsiella pneumoniae 30 (26%). Monomicrobial organisms in blood yielded a higher proportion in our study 72 (72%). The highest resistance for Acinetobacter species (50) was observed with ceftazidime 29 (96.6%) amikacin 48 (96%), meropenem 48 (96%), cefotaxime 47 (94%), ciprofloxacin 46 (92%), and netilmicin 46 (92%). K. pneumoniae was highly resistant to cefotaxime 29 (96.6%), ceftazidime 29 (96.6%), ciprofloxacin 22 (73.3%), and cefuroxime 21 (70%). Among Gram-positive organisms, Enterococcus species showed that a resistance for high-level gentamicin and penicillin was 66.6%.

Conclusions: Raised CRP, need of MV, prior antimicrobial exposure, and longer ICU stay should alarm clinicians for BSI. Hence, our study highlights the associated risk factors for BSI and emphasizes adherence to hospital infection control policies and antibiotic stewardship program.

导言:COVID-19 感染是一个持续存在的公共卫生危机,导致全球数百万人死亡。入住重症监护病房(ICU)的 COVID-19 患者更容易继发血流感染(sBSIs),从而导致严重的发病率和死亡率。因此,我们旨在评估 COVID-19 ICU 患者发生 sBSIs 的风险因素和结果:方法:收集 100 份有生长的血培养样本(病例)和 100 份无生长的血培养样本(对照)。对所有人口统计学数据、实验室数据和抗菌药耐药性模式进行了分析。微生物实验室收到的血培养瓶被装入自动血培养系统。通过 MALDI TOF 和自动抗生素药敏试验对标记瓶进行最终鉴定。通过 MALDI TOF 和自动抗生素药敏试验对标记瓶进行最终鉴定:结果:C反应蛋白(CRP)升高(P = 0.0035)、白细胞介素-6升高(P = 0.0404)、机械通气(MV)升高(P = 0.024)、既往抗菌药物暴露(P = 0.002)、ICU住院时间延长(中位 11 天)(P = 0.022)和死亡率升高(P = 0.001)与 BSI 显著相关。相当一部分 BSI 为革兰氏阴性菌(n = 115),如鲍曼不动杆菌 38 例(33%)和肺炎克雷伯菌 30 例(26%)。在我们的研究中,血液中单微生物的比例较高,为 72 (72%)。对头孢他啶29(96.6%)、阿米卡星48(96%)、美罗培南48(96%)、头孢他啶47(94%)、环丙沙星46(92%)和奈替米星46(92%)的耐药性最高(50)。肺炎双球菌对头孢他啶 29(96.6%)、头孢唑肟 29(96.6%)、环丙沙星 22(73.3%)和头孢呋辛 21(70%)高度耐药。在革兰氏阳性菌中,肠球菌对庆大霉素和青霉素的耐药率为 66.6%:结论:CRP 升高、需要使用 MV、之前接触过抗菌药物以及在重症监护室停留时间较长都应引起临床医生对 BSI 的警惕。因此,我们的研究强调了 BSI 的相关风险因素,并强调要遵守医院感染控制政策和抗生素管理计划。
{"title":"Associated Risk Factors and Clinical Outcomes of Bloodstream Infections among COVID-19 Intensive Care Unit Patients in a Tertiary Care Hospital.","authors":"Mahalakshmamma Dasarahalli Shivalingappa, Supriya Gachinmath, Shiva Kumar Narayan","doi":"10.4103/jgid.jgid_108_23","DOIUrl":"10.4103/jgid.jgid_108_23","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 infection is an ongoing public health crisis causing millions of deaths worldwide. COVID-19 patients admitted to the intensive care unit (ICU) are more vulnerable to acquire secondary bloodstream infections (sBSIs) which cause a significant morbidity and mortality. Thus, we aim to assess the risk factors of sBSIs and outcomes in COVID-19 ICU patients.</p><p><strong>Methods: </strong>One hundred blood culture samples with growth (cases) and other 100 blood culture with no growth(controls) were collected.. All the demographic data, laboratory data and antimicrobial resistance pattern were analysed . Blood culture bottle received in the Microbiology laboratory were loaded into Automated blood culture system. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing. Flagged bottles were processed for final identification by MALDI TOF and automated antibiotic susceptibility testing.</p><p><strong>Results: </strong>Raised C-reactive protein (CRP) (<i>P</i> = 0.0035), interleukin-6 (<i>P</i> = 0.0404), mechanical ventilation (MV) (<i>P</i> = 0.024), prior antimicrobial exposure (<i>P</i> = 0.002), longer ICU stay with median 11 days (<i>P</i> = 0.022), and higher mortality rate (<i>P</i> = 0.001) were significantly associated with the BSI. A significant proportion of BSIs were Gram-negative bacteria (<i>n</i> = 115) such as <i>Acinetobacter baumannii</i> 38 (33%) and <i>Klebsiella pneumoniae</i> 30 (26%). Monomicrobial organisms in blood yielded a higher proportion in our study 72 (72%). The highest resistance for <i>Acinetobacter</i> species (50) was observed with ceftazidime 29 (96.6%) amikacin 48 (96%), meropenem 48 (96%), cefotaxime 47 (94%), ciprofloxacin 46 (92%), and netilmicin 46 (92%). <i>K</i>. <i>pneumoniae</i> was highly resistant to cefotaxime 29 (96.6%), ceftazidime 29 (96.6%), ciprofloxacin 22 (73.3%), and cefuroxime 21 (70%). Among Gram-positive organisms, <i>Enterococcus</i> species showed that a resistance for high-level gentamicin and penicillin was 66.6%.</p><p><strong>Conclusions: </strong>Raised CRP, need of MV, prior antimicrobial exposure, and longer ICU stay should alarm clinicians for BSI. Hence, our study highlights the associated risk factors for BSI and emphasizes adherence to hospital infection control policies and antibiotic stewardship program.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 2","pages":"60-67"},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Case of Pneumocystis jirovecii Cystic Pneumonia. 一个不寻常的肺孢子虫囊肿性肺炎病例
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_33_24
Harpreet Singh, Deba Prasad Dhibhar, Vikas Suri, Ashish Bhalla
{"title":"An Unusual Case of <i>Pneumocystis jirovecii</i> Cystic Pneumonia.","authors":"Harpreet Singh, Deba Prasad Dhibhar, Vikas Suri, Ashish Bhalla","doi":"10.4103/jgid.jgid_33_24","DOIUrl":"10.4103/jgid.jgid_33_24","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 2","pages":"80-81"},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradoxical Reaction during Treatment of Tuberculous Meningoencephalitis in a Patient with Systemic Lupus Erythematosus. 系统性红斑狼疮患者在治疗结核性脑膜脑炎期间出现的矛盾反应
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2024-06-26 eCollection Date: 2024-04-01 DOI: 10.4103/jgid.jgid_96_23
Isadora Lemos Versiani, Gabriela Flor Nimer, Carolina Braga Moura, Arthur Ferreira Xavier, Rodrigo Cutrim Gaudio, Fernanda Cristina Rueda Lopes, Caroline Bittar Braune

Tuberculous paradoxical reaction presents as clinical deterioration during appropriate tuberculosis therapy and is a separate entity from treatment failure and drug resistance. We describe a case of central nervous system paradoxical reaction following tuberculous meningoencephalitis treatment in an immunocompromised patient with systemic lupus erythematosus.

结核病矛盾反应是在适当的结核病治疗过程中出现的临床恶化,与治疗失败和耐药性是两个不同的实体。我们描述了一例患有系统性红斑狼疮的免疫功能低下患者在接受结核性脑膜脑炎治疗后出现中枢神经系统矛盾反应的病例。
{"title":"Paradoxical Reaction during Treatment of Tuberculous Meningoencephalitis in a Patient with Systemic Lupus Erythematosus.","authors":"Isadora Lemos Versiani, Gabriela Flor Nimer, Carolina Braga Moura, Arthur Ferreira Xavier, Rodrigo Cutrim Gaudio, Fernanda Cristina Rueda Lopes, Caroline Bittar Braune","doi":"10.4103/jgid.jgid_96_23","DOIUrl":"10.4103/jgid.jgid_96_23","url":null,"abstract":"<p><p>Tuberculous paradoxical reaction presents as clinical deterioration during appropriate tuberculosis therapy and is a separate entity from treatment failure and drug resistance. We describe a case of central nervous system paradoxical reaction following tuberculous meningoencephalitis treatment in an immunocompromised patient with systemic lupus erythematosus.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"16 2","pages":"73-75"},"PeriodicalIF":1.0,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Global Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1